Matrix Metalloproteinase-8 Augments Bacterial Clearance in a Juvenile sepsis Model
Tóm tắt
Genetic ablation or pharmacologic inhibition of matrix metalloproteinase-8 (MMP8) improves survival in an adult murine sepsis model. Because developmental age influences the host inflammatory response, we hypothesized that developmental age influences the role of MMP8 in sepsis. First, we compared sepsis survival between wild-type (WT, C57BL/6) and MMP8 null juvenile-aged mice (12–14 d) after intraperitoneal injection of a standardized cecal slurry. Second, peritoneal lavages collected 6 h and 18 h after cecal slurry injection were analyzed for bacterial burden, leukocyte subsets and inflammatory cytokines. Third, juvenile WT mice were pretreated with an MMP8 inhibitor prior to cecal slurry injection; analysis of their bacterial burden was compared with vehicle-injected animals. Fourth, the phagocytic capacity of WT and MMP8 null peritoneal macrophages was compared. Finally, peritoneal neutrophil extracellular traps (NETs) were compared using immunofluorescent imaging and quantitative image analysis. We found that juvenile MMP8 null mice had greater mortality and higher bacterial burden than WT mice. Leukocyte counts and cytokine concentrations in the peritoneal fluid were increased in the MMP8 null mice relative to the wild-type mice. Peritoneal macrophages from MMP8 null mice had reduced phagocytic capacity compared to WT macrophages. There was no quantitative difference in NET formation, but fewer bacteria were adherent to NETs from MMP8 null animals. In conclusion, in contrast to septic adult mice, genetic ablation of MMP8 increased mortality following bacterial peritonitis in juvenile mice. This increase in mortality was associated with reduced bacterial clearance and reduced NET efficiency. We conclude that developmental age influences the role of MMP8 in sepsis.
Tài liệu tham khảo
Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the united states 2003 to 2007. Crit. Care Med. 2012;40:754–61.
Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pediatr. Crit. Care Med. 2005;6:S3–5.
Dellinger RP, et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med. 2013;41:580–637.
Wong HR, et al. Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol. Genomics. 2007;30:146–55.
Wynn JL, et al. The influence of developmental age on the early transcriptomic response of children with septic shock. Mol. Med. 2011;17:1146–56.
Cvijanovich N, et al. Validating the genomic signature of pediatric septic shock. Physiol. Genomics 2008;34:127–34.
Shanley TP, et al. Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol. Med. 2007;13:495–508.
Solan PD, Dunsmore KE, Denenberg AG, Odoms K, Zingarelli B, Wong HR. A novel role for matrix metalloproteinase-8 in sepsis. Crit. Care Med. 2012;40:379–87.
Wong HR, et al. The pediatric sepsis biomarker risk model. Crit. Care. 2012;16:R174.
Rella JM, Jilma B, Fabry A, Kaynar AM, Mayr FB. Mmp-8 genotypes influence the inflammatory response in human endotoxemia. Inflammation. 2014;37:451–56.
Wang H, et al. Functionally significant snp mmp8 promoter haplotypes and preterm premature rupture of membranes (pprom). Hum. Mol. Genet. 2004;13:2659–69.
Tester AM, et al. Lps responsiveness and neutrophil chemotaxis in vivo require pmn mmp-8 activity. PLoS One. 2007;2:e312.
Van Lint P, Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J. Leukoc. Biol. 2007;82:1375–81.
Quintero PA, Knolle MD, Cala LF, Zhuang Y, Owen CA. Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice. J. Immunol. 2010;184:1575–88.
Atkinson SJ, et al. Intestine-derived matrix metalloproteinase-8 is a critical mediator of polymicrobial peritonitis. Crit. Care Med. 2016;44:e200–6.
Wynn JL, et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by tlr agonists. Blood. 2008;112:1750–58.
Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, Division on Earth and Life Studies. (2011) Guide for the Care and Use of Laboratory Animals, 8th Edition. Washington, DC: National Academies Press [cited 2016 July 19].
Wynn JL, et al. Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock. 2007;28:675–83.
Barton P, et al. Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics. 2004;113:7–17.
Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the united states from 1979 through 2000. N. Engl. J. Med. 2003;348:1546–54.
Van Den Steen PE, Wuyts A, Husson SJ, Proost P, Van Damme J, Opdenakker G. Gelatinase b/mmp-9 and neutrophil collagenase/mmp-8 process the chemokines human gcp-2/cxcl6, ena-78/cxcl5 and mouse gcp-2/lix and modulate their physiological activities. Eur. J. Biochem. 2003;270:3739–49.
Silva MT. When two is better than one: Macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system. J. Leukoc. Biol. 2010;87:93–106.
Wynn JL, Neu J, Moldawer LL, Levy O. Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J. Perinatol. 2009;29:79–88.
Wynn JL, Seed PC, Cotten CM. Does ivig administration yield improved immune function in very premature neonates? J. Perinatol. 2010;30:635–42.
Wheeler DS, Wong HR, Zingarelli B. Pediatric sepsis—part I: “Children are not small adults!” Open Inflamm. J. 2011;4:4–15.
Ong CW, et al. Neutrophil-derived mmp-8 drives ampk-dependent matrix destruction in human pulmonary tuberculosis. PLoS Pathog. 2015;11:e1004917.